When Pfizer-BioNtech's experimental mRNA COVID-19 vaccine (a term that will be used rather loosely throughout this article) hit the market, in December 2020, it was met with a mixture of relief, excitement and pride in Germany, the country where it was developed.

The antiviral medication remdesivir has played a controversial role in the COVID-19 treatment protocols used by hospitals that many families allege resulted in the death of their loved ones. Among the drug's potential side effects is acute kidney failure, which many physicians argue is the source of the same symptom reported by the medical establishment to have been caused by COVID-19.